Although IL-4 and IL-13 are closely linked to the remodeling tissue process, it is suggested that asthmatic patients have a lower risk of developing the severe form of COVID-19 because they have increased levels of both interleukins and promote the suppression of angiotensin-converting enzyme II (ACE2)21. The gene discussed is IL13; the disease is COVID-19.